Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort

C. W. Scholz; Y. Karimi; H. Ghesquieres; W. Jurczak; C. Y. Cheah; M. R. Clausen; P. Lugtenburg; D. Cunningham; Y. R. Do; D. J. Lewis; R. Gasiorowski; T. M. Kim; M. van der Poel; M. L. Poon; T. Feldman; K. M. Linton; A. Sureda; M. Hutchings; Cota M. Stirner; Y. Liu; N. Kilavuz; M. Sacchi; C. Thieblemont

Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort

C. W. Scholz, Y. Karimi, H. Ghesquieres, W. Jurczak, C. Y. Cheah, M. R. Clausen, P. Lugtenburg, D. Cunningham, Y. R. Do, D. J. Lewis, R. Gasiorowski, T. M. Kim, M. van der Poel, M. L. Poon, T. Feldman, K. M. Linton, A. Sureda, M. Hutchings, Cota M. Stirner, Y. LiuN. Kilavuz, M. Sacchi, C. Thieblemont

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	268-269
Number of pages	2
Journal	Oncology Research and Treatment
Volume	46
Publication status	Published - 3 Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Scholz, C. W., Karimi, Y., Ghesquieres, H., Jurczak, W., Cheah, C. Y., Clausen, M. R., Lugtenburg, P., Cunningham, D., Do, Y. R., Lewis, D. J., Gasiorowski, R., Kim, T. M., van der Poel, M., Poon, M. L., Feldman, T., Linton, K. M., Sureda, A., Hutchings, M., Stirner, C. M., ... Thieblemont, C. (2023). Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort. Oncology Research and Treatment, 46, 268-269.

@article{0bff8c54b67548ae88f2753ade1da767,

title = "Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort",

author = "Scholz, {C. W.} and Y. Karimi and H. Ghesquieres and W. Jurczak and Cheah, {C. Y.} and Clausen, {M. R.} and P. Lugtenburg and D. Cunningham and Do, {Y. R.} and Lewis, {D. J.} and R. Gasiorowski and Kim, {T. M.} and {van der Poel}, M. and Poon, {M. L.} and T. Feldman and Linton, {K. M.} and A. Sureda and M. Hutchings and Stirner, {Cota M.} and Y. Liu and N. Kilavuz and M. Sacchi and C. Thieblemont",

year = "2023",

month = oct,

day = "3",

language = "English",

volume = "46",

pages = "268--269",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

}

Scholz, CW, Karimi, Y, Ghesquieres, H, Jurczak, W, Cheah, CY, Clausen, MR, Lugtenburg, P, Cunningham, D, Do, YR, Lewis, DJ, Gasiorowski, R, Kim, TM, van der Poel, M, Poon, ML, Feldman, T, Linton, KM, Sureda, A, Hutchings, M, Stirner, CM, Liu, Y, Kilavuz, N, Sacchi, M & Thieblemont, C 2023, 'Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort', Oncology Research and Treatment, vol. 46, pp. 268-269.

Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort. / Scholz, C. W.; Karimi, Y.; Ghesquieres, H. et al.
In: Oncology Research and Treatment, Vol. 46, 03.10.2023, p. 268-269.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

T2 - long-term results from the EPCORE NHL-1 Phase 2 expansion cohort

AU - Scholz, C. W.

AU - Karimi, Y.

AU - Ghesquieres, H.

AU - Jurczak, W.

AU - Cheah, C. Y.

AU - Clausen, M. R.

AU - Lugtenburg, P.

AU - Cunningham, D.

AU - Do, Y. R.

AU - Lewis, D. J.

AU - Gasiorowski, R.

AU - Kim, T. M.

AU - van der Poel, M.

AU - Poon, M. L.

AU - Feldman, T.

AU - Linton, K. M.

AU - Sureda, A.

AU - Hutchings, M.

AU - Stirner, Cota M.

AU - Liu, Y.

AU - Kilavuz, N.

AU - Sacchi, M.

AU - Thieblemont, C.

PY - 2023/10/3

Y1 - 2023/10/3

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001091456900601&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 2296-5270

VL - 46

SP - 268

EP - 269

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

ER -

Subcutaneous epcoritamab induces durable complete remissions in patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: long-term results from the EPCORE NHL-1 Phase 2 expansion cohort

UN SDGs

Other files and links

Cite this